Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) revealed earnings for its first quarter that Increased, from last year
The company's bottom line came in at RMB408.84 million, or RMB0.2447 per share. This compares with RMB325.95 million, or RMB0.1951 per share, last year.
The company's revenue for the period rose 3.4% to RMB2.439 billion from RMB2.358 billion last year.
Shijiazhuang Yiling Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB408.84 Mln. vs. RMB325.95 Mln. last year.-EPS: RMB0.2447 vs. RMB0.1951 last year.-Revenue: RMB2.439 Bln vs. RMB2.358 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.